Company / CapEx per Share
GT Biopharma, Inc. CapEx per Share History
FY2012-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
-
FY2017
5-year range
$0.00 / $0.00
FY2013-FY2017
Trend
-100.0%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.00 to $0.00 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, capex per share decreased 100.0% year-over-year.
- Peak capex per share was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2017 | $0.00 | -100.0% |
| FY2016 | $0.00 | -83.6% |
| FY2015 | $0.00 | - |
| FY2014 | $0.00 | -100.0% |
| FY2013 | $0.00 | - |
| FY2012 | $0.00 | - |
| FY2011 | - | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026